Solid-Phase Chemical Synthesis of Stable Isotope-Labeled RNA to Aid Structure and Dynamics Studies by NMR Spectroscopy

被引:17
|
作者
Becette, Owen [1 ]
Olenginski, Lukasz T. [1 ]
Dayie, Theodore K. [1 ]
机构
[1] Univ Maryland, Dept Chem & Biochem, Ctr Biomol Struct & Org, College Pk, MD 20742 USA
来源
MOLECULES | 2019年 / 24卷 / 19期
基金
美国国家科学基金会;
关键词
stable isotope; phosphoramidite; solid-phase synthesis; NMR spectroscopy; RNA; structure; dynamics; BIOLOGICAL-ACTIVITY; ENZYMATIC-SYNTHESIS; HYDROGEN-BONDS; N-15; NMR; PHOSPHORAMIDITES; C-13; NUCLEOTIDES; NUCLEOSIDES; OLIGORIBONUCLEOTIDE; 2'-DEOXYADENOSINE;
D O I
10.3390/molecules24193476
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
RNA structure and dynamic studies by NMR spectroscopy suffer from chemical shift overlap and line broadening, both of which become worse as RNA size increases. Incorporation of stable isotope labels into RNA has provided several solutions to these limitations. Nevertheless, the only method to circumvent the problem of spectral overlap completely is the solid-phase chemical synthesis of RNA with labeled RNA phosphoramidites. In this review, we summarize the practical aspects of this methodology for NMR spectroscopy studies of RNA. These types of investigations lie at the intersection of chemistry and biophysics and highlight the need for collaborative efforts to tackle the integrative structural biology problems that exist in the RNA world. Finally, examples of RNA structure and dynamic studies using labeled phosphoramidites are highlighted.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Isotope-Labeled RNA Building Blocks for NMR Structure and Dynamics Studies
    Olenginski, Lukasz T.
    Taiwo, Kehinde M.
    LeBlanc, Regan M.
    Dayie, Theodore K.
    MOLECULES, 2021, 26 (18):
  • [2] Stable Isotope-Labeled RNA Phosphoramidites to Facilitate Dynamics by NMR
    Wunderlich, Christoph H.
    Juen, Michael A.
    LeBlanc, Regan M.
    Longhini, Andrew P.
    Dayie, T. Kwaku
    Kreutz, Christoph
    ISOTOPE LABELING OF BIOMOLECULES - LABELING METHODS, 2015, 565 : 461 - 494
  • [3] SYNTHESIS AND NMR-SPECTROSCOPY OF STABLE ISOTOPE-LABELED PHENOLS AND L-TYROSINES
    WINKEL, C
    AARTS, MWMM
    VANDERHEIDE, FR
    BUITENHUIS, EG
    LUGTENBURG, J
    RECUEIL DES TRAVAUX CHIMIQUES DES PAYS-BAS-JOURNAL OF THE ROYAL NETHERLANDS CHEMICAL SOCIETY, 1989, 108 (04): : 139 - 146
  • [4] Chemical synthesis and NMR spectroscopy of long stable isotope labelled RNA
    Kremser, J.
    Strebitzer, E.
    Plangger, R.
    Juen, M. A.
    Nussbaumer, F.
    Glasner, H.
    Breuker, K.
    Kreutz, C.
    CHEMICAL COMMUNICATIONS, 2017, 53 (96) : 12938 - 12941
  • [5] Enzymatic incorporation of an isotope-labeled adenine into RNA for the study of conformational dynamics by NMR
    Feyrer, Hannes
    Gurdap, Cenk Onur
    Marusic, Maja
    Schlagnitweit, Judith
    Petzold, Katja
    PLOS ONE, 2022, 17 (07):
  • [6] Enzymatic incorporation of an isotope-labeled adenine into RNA for the study of conformational dynamics by NMR
    Feyrer, Hannes
    Gurdap, Cenk Onur
    Marusic, Maja
    Schlagnitweit, Judith
    Petzold, Katja
    PLOS ONE, 2022, 17 (05):
  • [7] Preparation of large RNA oligonucleotides with complementary isotope-labeled segments for NMR structural studies
    Andreas G Tzakos
    Laura E Easton
    Peter J Lukavsky
    Nature Protocols, 2007, 2 : 2139 - 2147
  • [8] Preparation of large RNA oligonucleotides with complementary isotope-labeled segments for NMR structural studies
    Tzakos, Andreas G.
    Easton, Laura E.
    Lukavsky, Peter J.
    NATURE PROTOCOLS, 2007, 2 (09) : 2139 - 2147
  • [9] Solid-phase synthesis of isotope-labeled 2-propyloctanoic acid, a therapeutic agent for stroke and Alzheimer's disease
    Ho, Jonathan Z.
    Tang, Cheng
    Braun, Matthew P.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [10] Solid-phase synthesis of isotope-labeled 2-propyloctanoic acid, a therapeutic agent for stroke and Alzheimer's disease
    Ho, Jonathan Z.
    Tang, Cheng
    Braun, Matthew P.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2007, 50 (5-6): : 496 - 497